03 December 2024
The Royal Society of Medicine
London, UK
Registration for this free networking event is now live.
03 December 2024
The Royal Society of Medicine
London, UK
Registration for this free networking event is now live.
Join SLAS and ELRIG in an extraordinary collaboration showcasing the latest pharmaceutical innovations. From revolutionary mRNA technologies to cutting-edge developments in antibodies and cell and gene therapies, immerse yourself in the dynamic evolution of drug discovery and therapeutics—experience the innovations setting the stage for a new era in medicine.
When: Tuesday 3 December 2024
Where: The Royal Society of Medicine
Royal Society of Medicine
1 Wimpole Street
London
W1G 0AE
This event is for industry leaders, researchers, and innovators to come together, share their groundbreaking ideas and delve into the transformative developments shaping the future of drug discovery and therapeutics. By highlighting the trailblazing innovations across new drug modalities and biologics, we aim to ignite collaboration, spark ingenuity and propel progress in the pharmaceutical sector.
| Tuesday 3 December, 2024 | |
| 9:00 – 10:00 | Registration & Refreshments |
| 10:00 – 10:10 | SLAS-ELRIG Welcome & Introduction |
| 1st Session | |
| 10:10 – 10:40 | Keynote Speaker + Q&A Chris Molloy (Medicines Discovery Catapult) Topic: Innovation and the discovery of new modality medicines - a view from MDC/UK |
| 10:40 – 10:55 | Forum Partner | BMG LABTECH Catherine Wark (BMG LABTECH) Topic: The PHERAstar FSX with Enhanced Dynamic Range and Advanced Assay Stability |
| 10:55 – 11:25 | Speaker + Q&A Lucy Edwardes Jones, M.Sc. (BGF) and Melissa Guven, Ph.D. (Monograph Capital) Topic: Innovation for new medicines from VC POV |
| 11:25 – 11:30 | Technology Spotlight | TBA |
| 11:30 – 12:10 | Refreshment Break |
| 12:10 – 12:40 | Speaker + Q&A Johanna Huchting, Ph.D. (Fraunhofer ITMP ScreeningPort) Topic: TPD screening workflows and showcase performance through examples of targets that are well-known and advanced in the TPD field |
| 12:40 – 12:45 | Technology Spotlight | Labman Liyah Dholiwar, M.Sc. (Labman) Topic: Designing unique lab technology that fits your workflow |
| 12:45 – 12:50 | Technology Spotlight | TBA |
| 12:50 – 13:20 | Speaker + Q&A Thomas Richardson, M.S., Ph.D. (Pear Bio) Topic: TBA |
| 13:20 – 14:40 | Lunch Break |
| 2nd Session | |
| 14:40 – 15:10 | Speaker + Q&A Pär Matsson, M.Sc., Ph.D. (University of Gothenburg) Topic: RNA, peptide therapeutics |
| 15:10 – 15:15 | Technology Spotlight | TBA |
| 15:15 – 15:45 | Speaker + Q&A Marija Mustapic, M.Sc. (Masterpiece Ventures) Topic: AI meets Meet Drug Modalities |
| 15:45 – 15:50 | Technology Spotlight | TBA |
| 15:50 – 15:55 | Technology Spotlight | TBA |
| 15:55 – 16:10 | SLAS Innovation AveNEW Speaker Jeroen Verheyen, Ph.D. (Semarion) SLAS Europe 2024 Innovation AveNEW Winner |
| 16:10 – 16:25 | ELRIG Drug Discovery Breakthrough Speaker William Lee, Ph.D. (Constructive Bio) ELRIG Drug Discovery Breakthrough Winner |
| 16:25 – 16:30 | Closing Remarks |
| 16:30 – 18:00 | Networking Apero |
This event will feature a variety of speakers. Each session will last 30 minutes (20 minutes for presentation, 10 minutes for Q&A). Learn more about each of our speakers ahead of the networking forum.
Topic: Innovation and the discovery of new modality medicines - a view from MDC/UK
Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. He began in preclinical research at Glaxo and then held leadership roles at MerLion Pharmaceuticals, IDBS and the RSA Group. As the founding CEO of Medicines Discovery Catapult (MDC), he leads an experienced executive team and a cohort of over 130 specialists to achieve the organization's vision of reshaping drug discovery for patient benefit.
Catherine Wark (BMG Labtech)
Topic: The PHERAstar FSX with Enhanced Dynamic Range and Advanced Assay Stability
Lucy Edwardes Jones, M.Sc. (BGF) and Melissa Guven, Ph.D. (Monograph Capital)
Topic: Innovation for new medicines from VC POV
Johanna Huchting, Ph.D. (Fraunhofer ITMP ScreeningPort)
Topic: TPD screening workflows and showcase performance through examples of targets that are well-known and advanced in the TPD field
Liyah Dholiwar, M.Sc. (Labman)
Topic: Designing unique lab technology that fits your workflow
Thomas Richardson, M.S., Ph.D. (Pear Bio)
Topic: TBA
Pär Matsson, M.Sc., Ph.D. (University of Gothenburg)
Topic: RNA, peptide therapeutics
Marija Mustapic, M.Sc. (Masterpiece Ventures)
Topic: AI meets Meet Drug Modalities
Jeroen Verheyen, Ph.D. (Semarion)
SLAS Europe 2024 Innovation AveNEW Winner: Semarion
William Lee, Ph.D. (Constructive Bio)
ELRIG Drug Discovery Breakthrough Winner
We are thrilled to provide the opportunity for drug discovery companies to connect directly with attendees and demonstrate their cutting-edge technologies. During each Technology Spotlight, one of our exhibitors will present a brief overview of its unique offerings.